TB drugs | DST | Region | p-value | Baseline n (%) | Follow up n (%) | Total n (%) | p-value | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
Hhohho n (%) | Manzini n (%) | Lubombo n (%) | Shiselweni n (%) | Total n (%) | |||||||
RIF | S | 25 (59.5) | 69 (61.6) | 13 (50) | 18 (69.2) | 125 (60.7) | 0.557 | 72 (69.9) | 53 (51.5) | 125 (60.7) | 0.005* |
R | 17 (40.5) | 43 (38.4) | 13 (50) | 8 (30.8) | 81 (39.3) | 31 (30.1) | 50 (48.5) | 81 (39.3) | |||
Total | 42 (100) | 112 (100) | 26 (100) | 26 (100) | 206 (100) | 103 (100) | 103 (100) | 206 (100) | |||
INH | S | 31 (73.8) | 82 (73.2) | 15 (57.7) | 22 (84.6) | 150 (72.8) | 0.197 | 80 (77.7) | 70 (68.0) | 150 (72.8) | 0.079 |
R | 11 (26.2) | 30 (26.8) | 11 (42.3) | 4 (15.4) | 56 (27.2) | 23 (22.3) | 33 (32.0) | 56 (27.2) | |||
Total | 42 (100) | 112 (100) | 26 (100) | 26 (100) | 206 (100) | 103 (100) | 103 (100) | 206 (100) | |||
STR | S | 28 (66.7) | 74 (66.1) | 16 (61.5) | 19 (73.1) | 137 (66.5) | 0.853 | 75 (72.8) | 62 (60.2) | 137 (66.5) | 0.038* |
R | 14 (33.3) | 38 (33.9) | 10 (38.5) | 7 (26.9) | 69 (33.5) | 28 (27.2) | 41 (39.8) | 69 (33.5) | |||
Total | 42 (100) | 112 (100) | 26 (100) | 26 (100) | 206 (100) | 103 (100) | 103 (100) | 206 (100) | |||
EMB | S | 29 (69) | 79 (70.5) | 17 (65.4) | 21 (80.8) | 146 (70.9) | 0.639 | 81 (78.6) | 65 (63.1) | 146 (70.9) | 0.011* |
R | 13 (31) | 33 (29.5) | 9 (34.6) | 5 (19.2) | 60 (29.1) | 22 (21.4) | 38 (36.9) | 60 (29.1) | |||
Total | 42 (100) | 112 (100) | 26 (100) | 26 (100) | 206 (100) | 81 (78.6) | 65 (63.1) | 146 (70.9) |